The comprehensive study scrutinized a massive dataset derived from Epic electronic health records, the most widely utilized system across U.S. hospitals and clinics. Analyzing more than 140 million patient records spanning 2,067 hospitals and 47,100 outpatient clinics, researchers evaluated over 8 billion documented interactions between patients and providers covering the period from January 2020 through December 2025. The findings provide unprecedented insights into the pandemic-driven acceleration and normalization of digital healthcare communications.

Published online in the Journal of the American Medical Association (JAMA) on June 22, 2026, the study reveals that patient messages routed through online portals more than doubled during this five-year window, increasing by a striking 153 percent. In stark contrast, traditional telephone communications decreased by 6 percent, signaling a fundamental shift in patient preference for digital messaging platforms over phone calls when managing appointments, test results, and ongoing treatments. Concurrently, the number of Americans with active Epic health records surged from 94 million in 2020 to 140 million in 2025, underscoring the rapid adoption of digital healthcare infrastructure nationwide.

Interestingly, the rise in digital portal usage has not come at the expense of in-person medical appointments. Instead, visits to healthcare providers have rebounded robustly since the pandemic’s height, stabilizing at an average of two to three office visits per patient annually. This coexistence of digital and physical care modalities suggests a hybrid model of healthcare delivery is emerging — one that enhances patient access and convenience while preserving the clinical benefits of face-to-face consultations.

The volume of patient-initiated messages has escalated sharply, with average annual communications rising from 2.2 per patient in early 2020 to 5.4 by late 2025. Senior investigator Michal A. Mankowski, PhD, assistant professor in the Department of Surgery at NYU Grossman School of Medicine, emphasized the significance of these findings, stating that digital health tools have become ingrained in everyday patient care rather than being peripheral or adjunct options. The increased accessibility to physicians and clinical staff suggests a shift toward more continuous, untethered healthcare interactions, no longer confined to scheduled appointments within traditional office hours.

Importantly, this new digital-first communication paradigm introduces additional operational complexity for healthcare providers. Co-investigator Dorry L. Segev, MD, PhD, professor and vice chair in Surgery at NYU Grossman, explained that digital workflows add layered demands atop established clinical duties. This necessitates forward-looking staffing strategies and innovative support systems to sustain provider efficiency and prevent burnout. Effective integration of messaging platforms, electronic clinical notes, online billing, and remote counseling are critical components in redesigning provider workflows for the digital age.

Dr. Segev highlighted the growing role of artificial intelligence in facilitating these transitions. NYU Langone is already implementing AI tools that expedite the drafting of clinical documentation and streamline provider communications, indicating a rapidly evolving technological ecosystem supporting modern medicine. AI-powered chatbots and content framing systems can reduce message complexity, enabling clinicians to focus on higher-value tasks while maintaining high-quality patient engagement and care continuity.

The vast scale and granularity of the Epic Cosmos dataset underpinning the study is notable. Covering over 300 million American patients’ records from a majority of Epic-using institutions, this repository offers a unique vantage point to analyze national healthcare trends. Despite Epic’s role as the largest electronic health record vendor, the study was conducted independently, with the company playing no direct role in data analysis to ensure scientific rigor and impartiality.

Beyond confirming the marked increase in digital communications, the study quantified interaction volumes: between 2020 and 2025, patients booked at least 1.77 billion in-person visits through Epic systems, sent 1.34 billion messages to providers, and received 3.25 billion portal messages in return. Telephone calls totaled 1.59 billion, with 146 million telehealth video visits logged, illustrating the multiplicity of engagement channels coexisting in contemporary healthcare delivery.

Looking ahead, the NYU Langone research team plans to delve deeper into regional and outpatient clinic-specific digital usage trends. This next phase aims to generate actionable insights capable of informing operational planning, resource allocation, and the customization of digital health services according to local healthcare ecosystem characteristics.

This pioneering study affords a valuable roadmap for healthcare systems navigating the digital transformation prompted by the COVID-19 pandemic and sustained technological advances. By demonstrating how patients and providers seamlessly integrate online messaging and portals with conventional visits, the research heralds a new era in which healthcare is increasingly continuous, accessible beyond office hours, and optimized through technological augmentation.

NYU Langone Health, the study’s home institution, is recognized nationally for outstanding clinical outcomes and academic leadership. The health system comprises multiple inpatient facilities, specialty centers such as the Perlmutter Cancer Center, and over 330 outpatient sites throughout New York and Florida. NYU Langone’s integration of cutting-edge digital tools exemplifies its commitment to innovation in patient care delivery.

This comprehensive investigation not only offers strategic insights to hospital administrators and clinicians but also highlights the imperative for training healthcare professionals to effectively navigate burgeoning digital workflows. Mastery of patient messaging platforms, AI-assisted documentation, and virtual counseling is fast becoming a core competency in modern medical practice.

In summary, the study presents a compelling portrait of a healthcare landscape in flux — one where the patient-provider relationship has expanded its temporal and spatial boundaries through secure online portals, while in-person care remains indispensable. The dual rise of digital and physical engagements reflects a balanced, hybrid model with transformative potential to enhance healthcare access, efficiency, and patient satisfaction across the United States.

Subject of Research: People
Article Title: Trends in Patient Portal Messages, Office Visits, and Telephone Encounters
News Publication Date: 22-Jun-2026
Web References: http://dx.doi.org/10.1001/jama.2026.8690
References: Journal of the American Medical Association (JAMA), 10.1001/jama.2026.8690
Keywords: Electronic medical records, Informatics

At the heart of this investigation lies an unsettling recognition: relying solely on diagnosis codes grossly underestimates the prevalence of self-harm, a risk factor intrinsic to predicting future suicide and guiding therapeutic interventions. Dr. Christophe Lambert, the study’s principal investigator and expert in translational informatics, emphasized that this “visibility gap” not only hampers research accuracy but also impedes clinical vigilance and resource allocation. Traditional coding is streamlined for ease, but the toll it extracts from subtle, narrative-rich notes within EHRs leaves many patients’ critical histories hidden from immediate view.

The study, published in the Journal of Medical Internet Research, utilized an advanced machine learning framework to penetrate this opacity. Unlike conventional approaches requiring definitive case and control groups, the team deployed a method known as Positive and Unlabeled Learning Selected Not At Random (PULSNAR). This technique excels in the chaotic terrain of real-world data, where the absence of a diagnostic code does not guarantee the absence of the condition itself. Instead, PULSNAR models the probability that certain patients possess an extensive but uncoded history of self-harm, capturing nuanced patterns from both coded records and the unstructured clinical notes that typify physician documentation.

Self-harm is more than a distressing event—its undocumented presence in EHRs poses a persistent risk for subsequent psychiatric crises, compounded by co-occurring disorders such as depression, post-traumatic stress disorder (PTSD), bipolar disorder, substance use disorders, and traumatic brain injury. These overlapping clinical landscapes necessitate complete, timely visibility of patient histories to inform both tailored treatment plans and system-wide mental health strategies. Unfortunately, even aggregations designed for clinical summation, such as problem lists, suffer from inconsistency and incompleteness. The research revealed that only approximately 22.6% of veterans with coded self-harm histories had this critical information reflected in their problem lists, further obscuring the data from those on the frontlines of care.

The implications of these gaps extend beyond individual clinical encounters to the broader realm of health services research and policy-making. Misclassification or undercounting of self-harm due to deficient coding can distort epidemiological insights and the allocation of limited mental health resources. Given that some EHRs in the study contained over half a million lines of clinical notes per patient, expecting individual clinicians to sift through this vast repository during routine visits is impractical. The reliance on codified data facilitates large-scale analysis but risks excluding a critical subset of patients due to documentation nuances.

The innovative machine learning approach employed in this study exemplifies a pivotal advance in health informatics. PULSNAR’s ability to learn from the labeled presence of diagnosis codes and infer probable but uncoded cases acknowledges the selective and non-random nature of medical coding. This method provides probabilistic estimates that align closely with expert chart reviews, suggesting a powerful tool for bridging the recognition gap in mental health documentation. The model identifies subtle indicators scattered through medical records, including risk factors, patterns of injury, and behaviors consistent with self-harm, which traditional coding may overlook.

Praveen Kumar, the first author, elucidated that these unrecorded patterns often remain buried within clinician notes, hidden from the structured data fields scrutinized by algorithms and reviewers alike. The study successfully validated only the pattern where self-harm was documented in narrative form yet uncoded. However, the broader challenge includes uncovering instances where self-harm is inferred indirectly through associated conditions and treatment patterns—a frontier requiring patient engagement and integration of data beyond the EHR.

This research signifies a collaborative triumph, pooling interdisciplinary expertise from medical informatics, psychiatry, computer science, economics, and statistics across multiple institutions, including the Raymond G. Murphy VA Medical Center and Vanderbilt University. The convergence facilitated the creation of a robust analytical framework designed to address real-world clinical data challenges. It highlights how precision in measuring mental health histories can enhance suicide prevention efforts, augment clinical decision-making, and enrich the scientific foundation for public health interventions.

The study aligns with a larger research initiative aimed at revealing under-documented conditions within medical records using positive-and-unlabeled learning methodologies. Previously, the team applied similar techniques to identify under-coded opioid use disorder, and ongoing projects extend this paradigm to other elusive conditions such as PTSD, depression, bipolar disorder, and sleep disorders. These endeavors collectively aim to expose the “hidden morbidity” that conventional medical data infrastructures frequently miss.

While the PULSNAR approach is not yet intended for frontline clinical deployment due to validation requirements and ethical considerations, its potential to complement existing suicide and overdose reporting tools is evident. By offering a scalable, data-driven lens that compensates for the known limitations of standardized coding systems, it equips healthcare organizations to identify patients with documented but obscure histories of self-harm more reliably. This, in turn, could streamline targeted interventions and resource deployment.

In an era where mental health crises are escalating, and healthcare systems grapple with increasingly complex data ecosystems, this research underscores the necessity of harnessing innovative computational techniques to reveal critical insights hidden in plain sight. The strategic integration of machine learning with clinical expertise exemplifies a vital path forward—transforming the overwhelming volume of clinical data into actionable knowledge that enhances patient safety and care quality.

Ultimately, these findings challenge the status quo, urging a paradigm shift in how healthcare frameworks capture and utilize mental health information. Dr. Lambert poignantly reflects on this systemic challenge, stating that self-harm history “matters too much to stay buried in records that are not practical to review line by line during routine care.” The researchers’ work offers a beacon for a future where technology augments human judgment, enabling clinicians and researchers to fully comprehend and address the realms of mental health that have long been shrouded by limitations in documentation and data accessibility.

Subject of Research: People

Article Title: Detecting Uncoded Self-Harm in Veterans’ Electronic Health Records Using Positive and Unlabeled Learning: Retrospective Cohort Study

News Publication Date: 4-Jun-2026

Web References:

• Journal of Medical Internet Research article
• DOI: 10.2196/89071
• PULSNAR Method Explanation

Keywords: Computer modeling, self-harm, electronic health records, machine learning, positive-unlabeled learning, mental health documentation, Veterans Health Administration, health informatics

Leading the charge, Dr. Neal Chatterjee and his team at the University of Washington School of Medicine have harnessed the combined power of machine learning and clinical data to create predictive models that could potentially alter clinical practice. Published in the esteemed journal JACC: Advances, the research employed a vast dataset encompassing nearly 1.7 million patient records from a large integrated healthcare system in the U.S., encompassing both EHR data and 12-lead EKGs. The team’s approach leverages three distinct AI models: one informed solely by EKG waveforms, another utilizing structured EHR inputs comprising more than 150 clinical variables, and a third hybrid model integrating both data sources.

The methodology underpinning the model development was rigorous, stratified across three patient cohorts to ensure robustness and real-world applicability. Initially, the training cohort consisted of 993 out-of-hospital cardiac arrest cases alongside 5,479 age- and sex-matched control subjects without cardiac events, spanning nearly a decade from 2013 to 2021. This comprehensive dataset allowed the AI to discern subtle patterns and predictors embedded in both the electrical signatures of the heart and broader health parameters that correlate with increased SCA risk.

Validation proceeded with a testing cohort from more recent years (2022-2023), which included 463 cardiac arrest incidents and nearly 3,000 controls. Application of the AI models here confirmed their predictive fidelity, with the models reliably distinguishing high- and low-risk profiles congruent with training findings. However, the true test came from applying the tools to a real-world cohort: a large, unfiltered group of nearly 40,000 individuals who had undergone EKG testing in 2021 regardless of pre-existing conditions, followed longitudinally for two years to see who eventually suffered cardiac arrest.

Remarkably, the integrated EHR-EKG AI model correctly identified 153 of the 228 patients who experienced cardiac arrest as high-risk, exhibiting an enrichment in risk prediction that elevated from a baseline of 1 in 1,000 to 1 in 100. This degree of stratification could be transformative in clinical settings, alerting healthcare practitioners and patients alike to a risk magnitude impactful enough to prompt preemptive clinical decisions and potentially lifesaving interventions.

Notably, the EKG-only model – which depends solely on the analysis of the heart’s electrical activity – demonstrated impressive prognostic capability independently, showing only a modest decrease in performance compared to models incorporating the full range of EHR data. Given the global ubiquity and low cost of 12-lead EKG machines, this finding unlocks practical pathways for broad implementation of risk screening even outside advanced healthcare environments.

Beyond cardiovascular parameters traditionally associated with SCA, the AI models illuminated novel risk factors often overlooked in clinical practice. These included electrolyte imbalances, substance use behaviors, and adverse medication interactions, highlighting how multifaceted cardiac arrest triggers can be. This insight suggests that AI-driven risk alerts might encourage clinicians to systematically review modifiable patient factors and perform more nuanced, preventive care tailored to the individual’s comprehensive clinical profile.

Despite this promise, Dr. Chatterjee and his collaborators underscore that predictive power alone is insufficient without clear clinical pathways. The next frontier is refining post-prediction responses: determining which diagnostic tests, monitoring regimens, or therapeutic interventions should follow identification of elevated risk. Clarifying these management strategies is paramount to translating AI prediction into tangible reductions in SCA incidence and mortality.

Another caveat relates to the study’s data source—all drawn from a single healthcare system—raising questions about the generalizability of the models to demographically or geographically distinct populations. Additionally, the real-world cohort limitation to individuals who had undergone EKG testing introduces selection bias; patients not receiving EKGs, who might nonetheless be at risk, remain outside the model’s purview. Furthermore, concerns about AI model biases linked to healthcare disparities and demographic representation warrant careful ongoing evaluation to ensure equitable, unbiased application across diverse patient populations.

The research, funded by prestigious entities including the National Institutes of Health, the American Heart Association, the European Union, and the Foundation Leducq, represents a multi-institutional collaborative success involving Massachusetts General Hospital and the Broad Institute at MIT and Harvard. The confluence of clinical cardiology expertise, data science innovation, and vast patient data has created an unprecedented predictive toolset with the potential to radically change how sudden cardiac arrest is anticipated and perhaps eventually prevented.

Dr. Chatterjee points to an exciting era ahead where artificial intelligence transforms the interpretation of routine medical tests from static snapshots into dynamic, predictive analyses capable of forewarning life-threatening events. This evolution heralds a future in which the frustration and tragedy of sudden cardiac arrest—long an enigmatic killer striking without warning—may become significantly mitigated through enhanced data-driven foresight integrated seamlessly into everyday clinical workflows worldwide.

Subject of Research: People
Article Title: Artificial Intelligence-Enhanced Electrocardiography and Health Records to Predict Cardiac Arrest
News Publication Date: 11-May-2026
Web References: DOI: 10.1016/j.jacadv.2026.102787
Keywords: Cardiac arrest, Artificial intelligence, Electrocardiography, Electronic medical records, Computer modeling

A groundbreaking study from Duke Health harnesses the power of AI to analyze routine electronic health records (EHRs) and estimate the risk of ADHD well before conventional clinical diagnosis occurs. The study, published in Nature Mental Health, dives deep into the wealth of clinical data accumulated in primary care settings. Researchers developed a sophisticated AI model trained on EHR data from more than 140,000 children, effectively unlocking hidden patterns across developmental, behavioral, and clinical parameters from birth through early childhood.

This AI-based predictive model is not a diagnostic instrument per se but functions as a risk stratification tool. It sifts through vast repositories of medical histories, identifying subtle, intricate interplays of variables that often presage an eventual ADHD diagnosis. Importantly, the model exhibits high predictive accuracy from the age of five onwards, maintaining robust performance across diverse demographics including sex, race, ethnicity, and insurance status. This generalizability marks a significant advance over previous attempts that often struggled with bias or limited datasets.

The transformative potential of such an AI-driven approach lies in its capacity to propel ADHD assessment into a proactive phase rather than reactive recognition. Typically, children with ADHD are diagnosed only after years of behavioral challenges and academic struggles. Early risk estimation equips pediatricians and primary care providers with actionable alerts, empowering them to closely monitor at-risk children and initiate timely referrals for comprehensive diagnostic evaluations by specialists.

Elliot Hill, the study’s lead author and a data scientist at Duke’s Department of Biostatistics & Bioinformatics, emphasizes the untapped richness of electronic health records. The AI effectively distills complex clinical narratives into predictive insights, demonstrating that everyday medical data can yield powerful prognostic signals that were previously inaccessible. Rather than creating an AI “doctor,” the model serves as an assistive technology aimed at optimizing clinician workflow and resource allocation.

Matthew Engelhard, M.D., Ph.D., the study’s senior author, underscores that automated tools like this could prevent many children from “falling through the cracks.” By spotlighting those who are at heightened risk, clinicians can allocate more focused attention and deploy evidence-based interventions sooner, which is strongly correlated with enhanced academic and psychosocial outcomes.

From a technical perspective, the AI model employs advanced machine learning techniques capable of integrating vast multidimensional data points, including developmental milestones, recorded behavioral issues, comorbid medical conditions, and even patterns indicating healthcare utilization. This holistic analysis leverages longitudinal data, allowing the system to discern trajectories rather than relying on static snapshots, which greatly enhances prediction accuracy.

Despite these promising results, the researchers caution that the AI tool requires further validation before widespread clinical adoption. Rigorous prospective studies and real-world trials are necessary to assess effectiveness, safety, and ethical implications. Additionally, integration within existing healthcare infrastructures presents logistical challenges, including data standardization, patient privacy considerations, and interoperability with diverse EHR systems.

Naomi Davis, Ph.D., an associate professor in the Department of Psychiatry and Behavioral Sciences and co-author, highlights the critical importance of connecting at-risk families with timely, evidence-based supports. Early identification must be paired with adequate resources and interventions tailored to each child’s unique needs, or else the benefits of predictive technology risk being lost.

This research aligns with a larger movement harnessing AI to predict and understand mental health risks across the lifespan. Hill and Engelhard have contributed additional studies exploring AI applications in adolescent mental illness, illustrating a growing commitment to integrating computational models into psychiatric epidemiology and personalized medicine.

The study benefits from robust funding by the National Institute of Mental Health and the National Center for Advancing Translational Sciences, signaling strong institutional support for leveraging AI as a transformative force in medical diagnostics. As the field continues to innovate, such AI-driven models may soon be integral to pediatric care, enabling clinicians to anticipate disorders like ADHD with unprecedented precision and intervene at life-changing early stages.

In summary, this pioneering work demonstrates that AI tools analyzing routine clinical data can efficiently predict ADHD risk long before traditional diagnoses arise. By embedding such technologies into everyday healthcare workflows, there is a distinct possibility of drastically transforming outcomes and quality of life for millions of children worldwide, delivering on the promise of precision medicine tailored from the very start of life.

Subject of Research: Early prediction of attention-deficit/hyperactivity disorder (ADHD) risk in children through artificial intelligence analysis of electronic health records

Article Title: Artificial Intelligence Models Predict Childhood ADHD Risk Years Before Diagnosis Using Routine Electronic Health Records

News Publication Date: April 27, 2026

Web References: https://www.nature.com/articles/s44220-026-00628-2

Image Credits: Duke Health / Shawn Rocco

Keywords

Attention-deficit/hyperactivity disorder, ADHD, artificial intelligence, AI, electronic health records, EHR, pediatric medicine, early diagnosis, machine learning, neurodevelopmental disorders, predictive modeling, mental health

Central to this study is the demonstration that genetic ancestry profoundly impacts how patients respond to therapies, particularly glucagon-like peptide-1 receptor agonists (GLP-1 RAs), commonly prescribed for weight loss and type 2 diabetes. The researchers found that therapeutic efficacy of GLP-1 drugs, such as semaglutide, varies significantly across different ancestral populations, and critically, this variability correlates with individuals’ genetic risk scores for type 2 diabetes. Such findings underscore the limitations of one-size-fits-all treatment approaches and herald a new era where genetic insights inform tailored medical interventions.

Utilizing integrative proteogenomic analyses, the team pinpointed a key genetic association between response to semaglutide and the gene PTPRU. This gene had not previously been linked to GLP-1 drug response, offering compelling evidence for its role in modulating treatment outcomes. Proteomics data from patients undergoing GLP-1 therapy further reinforced these findings, providing a molecular bridge between genotypic variation and phenotypic drug responsiveness. This discovery paves the way for future mechanistic studies and the potential development of predictive biomarkers to optimize obesity and diabetes therapies.

The ATLAS Biobank uniquely encompasses an expansive representation of ancestries, reflecting Los Angeles’ unparalleled ethnic diversity. Participants hail from five continental ancestries and encompass thirty-six fine-scale ancestry groups, including communities historically underrepresented in genetic research such as Armenian, Ashkenazi Jews, Iranian Jewish, Filipino, and Mexican American populations. This breadth allows for the disentanglement of genetic influences on health outcomes without confounding by healthcare system disparities, a common challenge when comparing data across institutions.

Historically, the majority of genomic studies have disproportionately sampled populations of European descent, limiting the applicability of findings to the global population and exacerbating health disparities. The UCLA ATLAS initiative confronts this bias head-on by drawing from one of the world’s most ancestrally diverse metropolitan areas—Los Angeles County—which boasts over 9.6 million residents. By integrating diverse genetic data with longitudinal clinical records within a single health system, this study establishes a paradigm for equitable precision medicine research.

Beyond common genetic variants, the study pioneers examination of rare variants within specific ancestry groups, unveiling hitherto unknown genetic correlations with disease phenotypes. For instance, the gene ANKZF1 was linked to peripheral vascular disease among African ancestry individuals, while EPG5 was associated with lipid metabolism traits such as HDL cholesterol and triglyceride levels in Ashkenazi Jewish participants. These discoveries highlight the importance of including rare variant analyses in multi-ancestry cohorts to illuminate genetic contributions to complex diseases.

The investigation also delineated ancestry-specific susceptibilities to adverse drug reactions. Among Mexicans and South Americans, increased vulnerability to negative hormonal therapy effects was observed, reinforcing the need for ancestry-informed pharmacovigilance. This awareness is critical for improving drug safety profiles and optimizing treatment plans for diverse populations, thereby enhancing patient outcomes and reducing health inequities.

A further significant dimension of the research involves polygenic risk scores (PRS), composite metrics summarizing genetic predispositions to diseases based on numerous variants spread across the genome. Within the ATLAS cohort, PRS demonstrated promising predictive power for conditions like type 1 diabetes, with a substantial proportion of patients exhibiting elevated scores matching their clinical diagnoses. Though clinical translation remains in early stages, these findings position PRS as a valuable tool for stratifying patient risk and guiding preventive strategies.

The researchers’ focus on GLP-1 receptor agonists as a case study showcases how genetic diversity can influence response to commonly prescribed medications. GLP-1 drugs, including branded agents such as Ozempic and Wegovy, have revolutionized treatment for obesity and diabetes but exhibit variable efficacy among individuals. Identifying genetic markers like those in PTPRU provides a molecular rationale for this heterogeneity and suggests pathways to develop predictive algorithms to personalize therapy.

Importantly, the UCLA Health system’s comprehensive real-world data environment—linking genetics with electronic health records—affords robust insights into disease pathogenesis and therapeutic outcomes within a clinical context. This approach contrasts with isolated laboratory investigations, elevating the translational potential of discoveries. As Dr. Daniel Geschwind, senior associate dean of Precision Health at UCLA, notes, ATLAS’s integration of broad and fine-scale ancestries illuminates genetic factors overlooked in earlier studies focused on broad ancestral categories alone.

Already, the ATLAS Biobank supports a public web portal presenting thousands of heritable genetic associations across diverse populations, enabling researchers worldwide to access and build upon these unprecedented data. With over 259,000 participants consented and 157,000 biospecimens collected since its launch in 2016, this initiative embodies a scalable model for genomic medicine research embedded within large health systems, fostering health equity by design.

The implications of these findings extend far beyond the academic sphere. They propel precision medicine closer to practical application, where individual genomic profiles guide risk assessment, diagnosis, and personalized treatments. Furthermore, this study is a call to action emphasizing the necessity of inclusive genetic research that respects and reflects population diversity to fulfill the promise of equitable, effective healthcare for all.

In conclusion, the UCLA Health-led study published in Cell underscores the transformative impact of integrating genetic diversity, clinical data, and molecular biology within a single health ecosystem. It highlights novel genetic determinants influencing disease risk and drug response, particularly in relation to type 2 diabetes and weight loss medications. By bridging gaps in ancestry representation and leveraging comprehensive real-world data, the work sets a new standard for precision health discovery and clinical translation, demonstrating that personalized medicine is not just a possibility for some but an achievable goal for the global population.

Subject of Research: Human tissue samples
Article Title: Advancing Precision Health Discovery in a Genetically Diverse Health System
News Publication Date: 27-Mar-2026
Web References: [UCLA ATLAS Community Health Initiative Biobank Web Portal] (link not provided in source)
References: DOI: 10.1016/j.cell.2026.03.007
Keywords: precision medicine, genetic diversity, GLP-1 receptor agonists, type 2 diabetes, polygenic risk scores, ancestry, genetic associations, semaglutide, pharmacogenomics, health disparities, rare genetic variants, proteomics

Suicide remains one of the foremost public health challenges among veterans receiving care within the Veterans Affairs (VA) health system. Traditional risk assessment tools, often reliant on structured clinical data and self-report questionnaires, have struggled with sensitivity and specificity issues. This limitation impedes early detection and intervention efforts, which are crucial for preventing suicide attempts. The newly introduced methodology capitalizes on advancements in computational linguistics, enabling more sophisticated analysis of clinical narratives, patient-provider communication, and other unstructured textual data embedded within electronic health records.

Natural language processing, a subfield of artificial intelligence, involves teaching computers to comprehend and interpret human language. While prior suicide risk prediction models have incorporated NLP, this study distinctively integrates multiple discrete NLP models, each specialized in capturing different linguistic and contextual dimensions. By doing so, the researchers overcome the pitfalls inherent in singular models that might overlook subtle but critical indicators expressed in natural language. This multi-model ensemble approach adeptly synthesizes diverse textual features to construct a comprehensive risk profile tailored for individual patients.

Central to this innovation is the recognition that suicide risk factors manifest in complex, multifactorial patterns within clinical notes and correspondences. Some models focus on sentiment analysis to detect emotional distress, while others evaluate temporal shifts in language indicative of worsening mental states or emerging suicidal ideation. Additional models examine semantic coherence, allowing the system to discern disorganized thought patterns linked to psychiatric conditions. The fusion of these discrete analytic perspectives empowers the predictive framework to transcend the constraints of conventional assessment paradigms.

To develop and validate their approach, the research team accessed an extensive corpus of VA patient records, meticulously anonymized to safeguard privacy. Their dataset encompassed millions of clinical notes spanning outpatient visits, hospitalizations, and mental health consultations. The diverse linguistic expressions across varying contexts presented both a challenge and an opportunity; however, by training discrete NLP models on tailored subsets of this data, the system achieved remarkable adaptability. This adaptability is pivotal given the heterogeneous nature of language used by patients and clinicians across different care settings.

Importantly, the model’s performance metrics demonstrated significant improvements over existing benchmarks. Predictive accuracy, measured by area under the receiver operating characteristic curve (AUC), surged substantially, signaling better identification of patients at imminent risk of suicide. Moreover, the system showed an enhanced capacity for early detection, flagging risk signals weeks or even months before traditional methods. This temporal advantage opens new avenues for preventive care strategies, optimizing resource allocation and fostering proactive clinical decision-making.

Beyond methodological rigor, the study underscores the ethical imperatives entwined with deploying AI-driven risk prediction tools in psychiatry. The researchers advocate for transparent model interpretability, ensuring that clinicians understand the basis for risk assessments. Such transparency is vital to maintaining trust and facilitating meaningful dialogue between patients and healthcare providers. Furthermore, the study emphasizes the necessity of continuous model evaluation to mitigate biases, especially critical when serving a demographically diverse veteran population with varying linguistic and cultural backgrounds.

The implications of this research extend far beyond the VA healthcare system. Mental health providers worldwide confront similar challenges in suicide prevention, particularly in managing large volumes of unstructured clinical data. The successful demonstration of integrating discrete NLP models suggests a scalable blueprint adaptable to other healthcare environments. Future iterations of such systems may incorporate additional data streams, including patient-generated texts, social media activity, or physiological sensors, further enriching the predictive landscape.

The study also prompts reflection on the evolving role of artificial intelligence in human-centered care. While technology enhances predictive capabilities, it is not a substitute for the empathy and nuanced judgment provided by mental health professionals. Instead, AI-powered tools should be viewed as augmentative, equipping clinicians with deeper insights without supplanting the critical human dimension of care. The researchers envision collaborative frameworks where AI and clinicians operate synergistically to formulate personalized, timely, and effective intervention plans.

Looking ahead, the research team is exploring pathways to integrate their models into real-time clinical workflows. Such integration necessitates overcoming operational challenges, including seamless interfacing with existing electronic health record systems, ensuring data security, and establishing protocols for alert management. The ultimate goal is to embed these predictive tools within routine patient care, rendering suicide risk assessment both continuous and dynamic rather than a sporadic, subjective endeavor.

Moreover, the study ignites exciting prospects for interdisciplinary collaboration. By bringing together experts in computational linguistics, psychiatry, bioinformatics, and healthcare policy, the team demonstrates the power of convergent approaches in tackling complex mental health crises. This synergy is crucial for translating technological innovations into tangible improvements in patient outcomes, especially in vulnerable populations such as veterans, who face unique stressors related to combat exposure, reintegration challenges, and comorbidities.

The enhancement of personalized suicide risk prediction through discrete NLP models represents a paradigm shift in mental health analytics. It embodies a broader transformation where AI not only processes big data but interprets it in contextually rich, clinically meaningful ways. Such advanced analysis fosters earlier, more accurate identification of high-risk individuals, enabling interventions that are timely, targeted, and potentially life-saving. As suicide rates continue to pose alarming public health concerns, innovations like these offer a beacon of hope.

As the technology matures, ongoing research will be critical to assess real-world effectiveness, patient acceptance, and cost-benefit ratios. Ethical oversight, patient privacy, and the prevention of unintended consequences such as stigmatization remain paramount considerations. However, this pioneering work signals a promising trajectory toward harnessing AI’s full potential in mental healthcare, ultimately contributing to reduced suicide incidence and improved well-being among veterans and beyond.

In conclusion, the integration of multiple discrete natural language processing models heralds a new era in suicide risk prediction, offering profound enhancements in accuracy and personalization. This sophisticated approach unlocks the latent informational wealth embedded in clinical text, transforming it into actionable clinical intelligence. As we embrace these advanced computational tools, we move closer to realizing a healthcare paradigm that is not only data-informed but profoundly human-centric—saving lives through science and empathy intertwined.

Subject of Research: Enhancing suicide risk prediction in veterans through integrative natural language processing models

Article Title: Enhancing personalized suicide risk prediction for VA patients by integrating discrete natural language processing models

Article References:

Dimambro, M., Levy, J., Gui, J. et al. Enhancing personalized suicide risk prediction for VA patients by integrating discrete natural language processing models.
Transl Psychiatry (2026). https://doi.org/10.1038/s41398-026-03940-8

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41398-026-03940-8

Traditionally, cardiometabolic risk prediction algorithms have been developed with the general population in mind, often targeting middle-aged or older adults. This approach has inherently neglected the unique physiological and lifestyle factors prevalent in younger cohorts, especially those grappling with psychosis. PsyMetRiC 2.0 bridges this divide by utilizing a refined algorithm, honed through the rigorous analysis of anonymized health data from over 25,000 young people with psychosis in the United Kingdom, whose clinical trajectories were tracked longitudinally over two decades.

The methodology employed is a landmark in predictive modeling: by harnessing real-world electronic health records, researchers created a model capable of predicting three critical outcomes. Within one year, it estimates significant weight gain; over six years, the onset of metabolic syndrome; and within ten years, the development of type 2 diabetes. These outcomes were chosen not merely for their clinical relevance but also for their resonance with patient priorities, ensuring the tool’s recommendations are grounded in shared decision-making principles.

What differentiates PsyMetRiC’s approach is its conscientious design for utility and fairness. It was rigorously validated across multiple international cohorts, including populations in Spain, Switzerland, Finland, the Netherlands, Canada, Hong Kong, and Australia, demonstrating robust predictive performance beyond the UK. Furthermore, the designers incorporated feedback from clinicians, carers, and those with lived experience of psychosis, in partnership with organizations such as the McPin Foundation and The Centre for Mental Health. This collaborative process ensured that the tool not only delivers precise risk assessments but also communicates these risks in a manner that is accessible, culturally sensitive, and motivating for patients.

At the core of PsyMetRiC 2.0’s architecture is advanced statistical analysis and machine learning techniques applied to large-scale, longitudinal datasets. By identifying complex interactions between demographic factors, clinical presentations, medication regimens—particularly antipsychotic-induced metabolic side effects—and lifestyle parameters like diet, exercise, and smoking, the algorithm provides personalized risk profiles. The predictive models incorporate both fixed and dynamic variables, accounting for changes in health status over time, which enhances their clinical relevance in monitoring disease progression and guiding timely interventions.

A significant achievement of PsyMetRiC is its certification by the UK Medicines & Healthcare products Regulatory Agency (MHRA) as a Class 1 Medical Device. This regulatory endorsement is historic within psychiatry, underscoring the tool’s safety, efficacy, and readiness for integration into routine clinical workflows. Its deployment offers a paradigm shift, encouraging clinicians to move beyond reactive care and towards proactive, prevention-oriented strategies tailored to the complex needs of young people with severe mental illness.

The clinical implications of deploying PsyMetRiC extend beyond individual patient outcomes. People living with psychosis experience substantially reduced life expectancy, averaging a 15-year gap compared to the general population, predominantly due to preventable cardiometabolic diseases. Early identification of risk allows for the initiation of lifestyle modifications and pharmacological treatments—such as metformin or statins—aimed at mitigating weight gain and metabolic disturbances. The availability of a quantifiable risk score also facilitates nuanced conversations between healthcare providers and patients, helping dismantle barriers related to health literacy and stigma.

Emphasizing patient engagement, PsyMetRiC’s risk reports are multifaceted, incorporating numeric probabilities alongside graphical visualizations, ranging from traditional risk charts to innovative ‘heart age’ analogues. This multimodal communication strategy caters to diverse patient preferences and cognitive styles, enhancing comprehension and fostering behavior change. Importantly, educational materials co-produced with individuals with lived experience accompany the application, guiding clinicians on optimal risk discussion techniques to maximize impact.

The research underpinning PsyMetRiC 2.0 is published in the highly regarded journal The Lancet Psychiatry, signaling its scientific rigor and clinical significance. The study employed retrospective multicohort analysis with sophisticated data/statistical methods, ensuring that the model’s validations are both methodologically sound and clinically applicable. Planned future directions include refining the algorithm using results from ongoing qualitative and health economic evaluations, as well as expanding its validation in non-UK populations, including forthcoming trials in the United States.

The developers recognize that health inequities are embedded within many datasets, potentially propagating bias in predictive models. By actively seeking to test and correct for such biases, PsyMetRiC represents an important step toward equitable healthcare delivery. The tool aims to serve patients from diverse ethnic and socioeconomic backgrounds, addressing disparities that have historically marginalized these groups in physical health management.

In summary, PsyMetRiC 2.0 embodies a convergence of advanced analytics, patient-centered design, and regulatory validation, poised to revolutionize the management of cardiometabolic risk in young people with psychosis. Its introduction marks a pivotal moment in psychiatric medicine, promising to reduce premature mortality through early, personalized intervention. As this tool gains traction in clinical settings, it holds the potential to reshape how mental and physical health intersect in vulnerable populations globally.

Subject of Research: People
Article Title: Cardiometabolic prediction models for young people with psychosis spectrum disorders in the UK (PsyMetRiC 2.0): a retrospective, multicohort clinical prediction model study
News Publication Date: 11-Mar-2026
Web References:

• PsyMetRiC Web Application: https://psymetric.app/
• Lancet Psychiatry Article: https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(25)00398-0/fulltext
  References:
• Perry, B. et al., “Cardiometabolic prediction models for young people with psychosis spectrum disorders in the UK (PsyMetRiC 2.0),” The Lancet Psychiatry, 2026.
• Original PsyMetRiC Validation Study: https://pmc.ncbi.nlm.nih.gov/articles/PMC8211566/
  Keywords: Psychotic disorders, Cardiometabolic risk, Metabolic syndrome, Type 2 diabetes, Obesity, Machine learning, Health equity, Psychiatry, Predictive modeling

Eligibility criteria form the bedrock of clinical trial enrollment, dictating which patients may or may not participate based on intricate clinical, demographic, and sometimes genomic data. Traditionally, this process has been laborious, tediously conducted by skilled clinical research coordinators and physicians manually reviewing patient records. The sheer volume of data, combined with the complex medical language and nuanced clinical context embedded within EHRs, can produce substantial delays and errors in patient selection. These inefficiencies invariably slow trial recruitment and prolong the time necessary to advance promising oncology therapies to market.

The study takes advantage of retrospectively curated EHRs, applying a randomized controlled trial design to evaluate the combinatorial power of AI and human judgment. Advanced natural language processing (NLP) algorithms transformed unstructured clinical notes and structured data into standardized formats interpretable by machine learning models. These AI systems were trained to pre-screen patients rapidly against multifaceted protocol eligibility rules, identifying candidates with a high probability of meeting trial inclusion criteria. Crucially, the AI output was then reviewed by human clinical experts who could confirm, override, or refine selections, blending the speed of computation with nuanced human insight.

Results from this hybrid screening framework defied traditional assumptions that machines alone suffice or that human effort alone is superior. Instead, the team demonstrated significant gains in accuracy and efficiency through their human-AI teaming approach. Compared to manual prescreening, the combined method more effectively sifted through potentially eligible patients, reducing false positives and negatives alike. This led to not only quicker patient identification but also better allocation of clinical research resources, minimizing unnecessary follow-up assessments on ineligible candidates.

Technologically, the backbone of the AI system involved cutting-edge deep learning architectures optimized for clinical text mining. Applying transformer-based models, fine-tuned on domain-specific corpora, enabled the extraction of complex clinical concepts relevant to oncology protocols. The researchers emphasized the importance of interpretability, providing clinicians with transparent rationale behind AI-generated eligibility flags. This interpretability fostered trust among human reviewers, an essential factor ensuring adoption of AI tools in sensitive decision-making processes.

Beyond efficiency, ensuring equitable patient selection emerged as a key benefit of the human-AI synergy. Traditionally, human bias and cognitive overload can inadvertently skew screening towards subsets of patients, risking underrepresentation of minorities or rare clinical phenotypes. The AI’s standardized evaluation criteria helped to mitigate unintended screening biases, while humans provided contextual awareness to prevent exclusion of borderline cases that might be unjustly disregarded by rigid algorithms.

The implications of this research extend far beyond oncology. The scalable human-AI team-based prescreening framework promises transformative impact across numerous clinical domains where eligibility criteria are complex and data voluminous—a common challenge in cardiovascular disease trials, infectious disease studies, and neurology as well. The marriage of AI’s data-processing speed with human judgment’s contextual granularity could redefine clinical trial workflows universally.

However, the journey to integration is not without hurdles. The authors note that successful deployment necessitates seamless integration with clinical informatics infrastructures, robust data privacy protections, and ongoing training of AI systems to adapt to evolving trial protocols and populations. Additionally, regulatory acceptance of AI-assisted screening processes remains an evolving landscape requiring transparent validation and auditability.

This study epitomizes the future of modern clinical trials in an era increasingly dominated by Big Data and AI. By thoughtfully combining the strengths of human cognition and machine intelligence, Parikh and colleagues have paved a path toward more rapid, equitable, and reliable patient enrollment. Their work captures not merely a technical achievement but a paradigm shift in clinical research methodologies—ushering in a new generation of precision trial design empowered by human-AI collaboration.

As clinical trials remain fundamental to discovering novel cancer treatments and improving patient outcomes globally, this advancement could expedite breakthroughs that save lives. It resolves a critical bottleneck in the clinical development pipeline, enabling scientists and clinicians to focus less on onerous manual screening and more on therapeutic innovation and patient care.

Looking ahead, further research is anticipated to explore refining AI models to incorporate real-time patient updates, social determinants of health, and patient-reported outcomes into eligibility assessments. Integration with digital biomarkers and wearables could enrich data inputs, empowering even more personalized, dynamic trial matching. Moreover, the ethical, legal, and social implications of AI-human partnerships in clinical research will warrant continued dialogue among stakeholders to ensure responsible and equitable technology use.

Ultimately, this landmark investigation illustrates that the future of clinical trials lies not in choosing between humans or machines but in harnessing the distinct advantages of both. The synergy unleashed by human-AI teaming stands as a beacon for transformative clinical research innovation, offering new hope for speeding development of life-saving cancer therapies worldwide.

Subject of Research: Human-AI collaboration for improving accuracy and efficiency in eligibility prescreening for oncology clinical trials using retrospective electronic health records.

Article Title: Human-AI teaming to improve accuracy and efficiency of eligibility criteria prescreening for oncology trials: a randomized evaluation trial using retrospective electronic health records.

Article References:

Parikh, R.B., Kolla, L., Beothy, E.A. et al. Human-AI teaming to improve accuracy and efficiency of eligibility criteria prescreening for oncology trials: a randomized evaluation trial using retrospective electronic health records.
Nat Commun (2026). https://doi.org/10.1038/s41467-026-68873-8

Image Credits: AI Generated

Weight stigma—the social devaluation and discrimination based on a person’s body size—is an insidious phenomenon known to compromise physical and psychological health across numerous settings. While previous studies have documented its presence in various healthcare interactions, few have rigorously examined its manifestation within maternity care settings, and even fewer have analyzed the actual language used within medical records. The current study fills this crucial gap, employing advanced natural language processing techniques and qualitative analyses to scrutinize hundreds of hospital birth admission notes. By focusing on the documented language, the researchers provide a rare, unfiltered window into the clinical attitudes and implicit biases retained within the healthcare system.

At the core of the research lies an intricate analysis of electronic health records from multiple hospitals, targeting the admission notes compiled at the time of delivery hospitalization. These notes typically contain clinicians’ initial assessments, patient histories, and preliminary treatment plans—an arena where language choice can subtly reflect clinicians’ perceptions and attitudes toward patients. By examining the frequency, context, and nature of language describing patients’ body weight, the study reveals a troubling pattern: women with higher body mass index (BMI) are disproportionately described using terms that carry negative connotations, often emphasizing risk factors and complications in ways that border on judgment rather than objective medical concern.

The findings demonstrate that stigmatizing language, including descriptors with implicit bias such as “non-compliant,” “difficult,” or focusing excessive attention on weight-related risks, appears more frequently in notes concerning women identified as having higher BMI. Such language not only perpetuates stereotypes but may inherently influence subsequent care decisions, patient-clinician interactions, and overall maternal outcomes. The results suggest that beyond clinical facts, subjective and value-laden language infiltrates documentation in ways that potentially exacerbate healthcare disparities and emotional distress for already vulnerable patients.

One of the study’s remarkable contributions is its use of natural language processing algorithms to systematically quantify and categorize stigmatizing language across large datasets of admission notes. This technological approach allowed the researchers to move beyond anecdotal evidence and small-scale qualitative studies to generate robust, scalable insights about bias embedded within the electronic health record system. Such methodological innovation highlights the power of combining computational tools with clinical insights to address social justice issues in medicine.

The researchers contextualize their findings within a broader framework of healthcare equity and patient-centered care. They emphasize how stigmatizing language in medical documentation not only harms the immediate psychological well-being of pregnant women with higher weight but also contributes to long-term avoidance of prenatal care and poorer maternal and neonatal outcomes. The study calls for systemic reforms including provider education on respectful communication, institutional guidelines to mitigate biased language in EHRs, and reformation of documentation practices towards affirming, objective descriptions that respect patient dignity.

Throughout the analysis, the study underscores the intersectionality of stigma in maternity care, recognizing how weight intersects with other axes of marginalization, such as race, socioeconomic status, and access to care. Women from historically disadvantaged communities who also experience higher rates of obesity may face compounded layers of discrimination reflected both in clinical interactions and the records that shape their future care trajectories. This critical observation urges a more holistic approach in addressing health disparities through structural changes in documentation and provider training.

Furthermore, the research evaluates how the documented stigmatizing language could impact clinical decision-making. The presence of biased descriptors may inadvertently influence care teams to discount patient autonomy, reinforce paternalistic practices, or justify unequal treatment intensity based on weight-related assumptions rather than evidence-based protocols. This potential distortion underscores the urgency for healthcare systems to audit and reform their documentation standards in pursuit of equitable and unbiased care.

In highlighting the real-world implications of stigmatizing medical documentation, the study also touches on the psychological impact for pregnant women encountering such language when they access their medical records under patient rights regulations. Encountering judgmental terminology can contribute to feelings of shame, reduced trust in healthcare providers, and emotional distress in a phase already fraught with vulnerability and anticipation. The study’s findings invite healthcare systems to rethink transparency and patient access policies with sensitivity to language.

Moreover, the study calls attention to the role of electronic health record software design in shaping documentation practices. The researchers note that standard templates and prompts often emphasize risk factors linked to weight in ways that may predispose clinicians to adopt biased language. This insight opens opportunities for technology developers to integrate bias-mitigating algorithms and prompts that encourage neutral, factual, and respectful documentation—transforming EHRs from passive data repositories into active tools for equitable care.

Beyond the immediate clinical setting, the research has significant ramifications for public health policy and maternal health advocacy. By documenting concrete patterns of language-based bias, the study furnishes evidence that can inform policy interventions aiming to reduce weight stigma in healthcare guidelines and accreditation standards. Advocates for maternal health equity may leverage these findings to demand greater accountability and community-centered reforms in maternity care systems.

Importantly, the researchers point to the need for further interdisciplinary investigation combining sociolinguistics, clinical medicine, and informatics to deepen understanding of stigma mechanisms in medical documentation. Future studies may explore how training interventions affect clinicians’ documentation habits or assess the longitudinal impacts of stigmatizing language on health outcomes. This study lays the groundwork for such ongoing inquiry by establishing a replicable analytical framework.

The revelation that stigmatizing language is ingrained within routine clinical documentation during a pivotal healthcare encounter—hospital birth admission—shines a spotlight on an area often overlooked in discussions about implicit bias in medicine. It challenges health systems, providers, and policymakers to confront uncomfortable truths about how language reflects and perpetuates inequities, urging a commitment to empathetic, respectful, and scientifically grounded care for pregnant women of all body sizes.

In conclusion, this landmark study exposes hidden biases etched into the fabric of maternity care documentation and calls for urgent action to disrupt cycles of weight stigma in clinical environments. By pioneering methods to detect and address stigmatizing language in electronic health records, the research paves a hopeful path toward more compassionate, equitable childbirth experiences. With rising rates of higher body weight globally intersecting with maternal health challenges, these findings arrive at a critical juncture—demanding that the care entrusted to pregnant women reflects dignity, respect, and unbiased medical science above all.

Subject of Research: The association between higher body weight and stigmatizing language documented in hospital birth admission electronic health records.

Article Title: The association between higher body weight and stigmatizing language documented in hospital birth admission notes.

Article References:
Harkins, S.E., Hazi, A.K., Hulchafo, I.I. et al. The association between higher body weight and stigmatizing language documented in hospital birth admission notes. Int J Obes (2026). https://doi.org/10.1038/s41366-025-01965-5

Image Credits: AI Generated

DOI: 13 January 2026

As our society ages, the importance of recognizing and addressing geriatric syndromes becomes paramount. These syndromes encompass a range of conditions such as frailty, delirium, falls, and incontinence, which often occur concurrently and complicate individual health management. The study highlights that current healthcare systems are often ill-equipped to manage these overlapping conditions effectively. By leveraging the vast amounts of data housed within electronic health records, healthcare providers can enhance their ability to detect and respond to these syndromes proactively.

Electronic health records are a treasure trove of patient information, capturing various aspects of an individual’s health history, treatments, and responses to care. Researchers have started to utilize natural language processing (NLP) and machine learning techniques to sift through these extensive datasets. The application of these advanced technologies enables the identification of patterns and insights that may be overlooked in traditional clinical assessment. By automating the extraction process, practitioners can glean a comprehensive understanding of geriatric syndromes affecting their patients.

One significant advantage of extracting geriatric syndromes from EHRs is the potential for improving preventative care strategies. Knowing which syndromes are prevalent within specific populations allows for tailored interventions that are both timely and effective. For instance, if a certain healthcare facility identifies a high incidence of falls among its elderly patients through EHR analysis, it can implement fall-prevention programs specifically designed to address this issue. By being proactive, healthcare providers can mitigate risks before they culminate in severe health consequences for their patients.

The scoping review conducted by Squires et al. delves deeply into the various methodologies employed in the extraction of geriatric syndromes from EHRs. The researchers uncovered a range of both quantitative and qualitative techniques employed to process and analyze health data. These methodologies predominantly rely on the integration of interdisciplinary approaches, combining insights from geriatricians, data scientists, and IT specialists to create a multifaceted understanding of the challenges at hand. The integration of artificial intelligence into the analysis has shown promising results, indicating that these technologies could significantly enhance diagnostic accuracy and treatment planning.

However, the study also identifies several hurdles in the implementation of EHR extraction methods. One major concern revolves around the quality and completeness of data recorded in electronic health systems. Inconsistent coding practices, incomplete patient information, and variations in healthcare provider documentation can lead to significant gaps in data that hinder accurate analysis. Addressing these challenges requires improved training for healthcare professionals on proper documentation practices and a commitment from institutions to uphold high standards of data integrity.

Furthermore, ethical considerations play a pivotal role in the extraction and analysis of geriatric health data. Protecting patient privacy must remain a top priority as healthcare systems increasingly rely on data-driven approaches. The researchers emphasize the importance of adhering to legal regulations and ethical standards when utilizing electronic health records for research and clinical purposes. Safeguarding sensitive patient information is not just a legal requirement, but a moral imperative that fosters trust between patients and healthcare providers.

As the study illustrates, the potential applications of EHR data analysis extend far beyond clinical settings. Policymakers can leverage insights gained from this research to inform public health strategies aimed at improving the overall well-being of aging populations. By identifying prevalent geriatric syndromes, public health officials can allocate resources more effectively and develop community interventions focused on prevention and education. This holistic strategy could result in lowered healthcare costs and improved quality of life for older adults across the globe.

Additionally, the findings suggest that interdisciplinary training should be emphasized across medical professions. Training healthcare providers in both geriatric care and data analysis can cultivate a workforce adept at tackling the complexities of aging populations. By fostering collaboration among healthcare professionals, researchers, and policymakers, the study underscores the necessity for a unified approach to managing geriatric syndromes.

With the rise of telemedicine and remote patient monitoring, the potential for utilizing electronic health records expands even further. The ability to assess and track aging patients remotely can offer critical insights into their health status in real-time. This approach could revolutionize how healthcare teams interact with older adults, allowing for rapid intervention when concerning trends are identified. Implementing these technologies in conjunction with EHR data analysis could transform geriatric care delivery on a fundamental level.

Looking toward the future, the insights gleaned from the study by Squires et al. could pave the way for new research initiatives aimed at refining EHR extraction processes. Further exploration is necessary to optimize these methodologies for accuracy, reliability, and efficiency. As technological advancements continue to emerge, researchers must remain vigilant in adapting their approaches to harness the potential of these innovations.

In conclusion, the extraction of geriatric syndromes from electronic health records presents an extraordinary opportunity to enhance the quality of care available to older adults. The research conducted highlights the pivotal role that advanced data analysis can play in identifying and addressing health challenges faced by this demographic. As healthcare continues to evolve, embracing the integration of technology and interdisciplinary collaboration will be essential to meeting the needs of aging populations effectively. The path forward necessitates a collective commitment to advancing geriatric care through research, policy, and practice.

In an era where healthcare systems are increasingly burdened by the demands of aging populations, the importance of innovative solutions cannot be overstated. The findings of this scoping review serve as a clarion call for healthcare leaders to embrace the potential of electronic health records as an invaluable tool in the fight against geriatric syndromes. By prioritizing the development of robust extraction methodologies, investing in training, and maintaining ethical standards, the healthcare community can significantly improve outcomes for older adults, ensuring they receive the comprehensive care they deserve.

Subject of Research: Geriatric syndromes and electronic health records.

Article Title: Extracting geriatric syndromes from electronic health records: a scoping review.

Article References:

Squires, C., Duignan, A., Peterson, A. et al. Extracting geriatric syndromes from electronic health records: a scoping review.
Eur Geriatr Med (2026). https://doi.org/10.1007/s41999-025-01388-5

Image Credits: AI Generated

DOI: 09 January 2026

Keywords: geriatric syndromes, electronic health records, healthcare, data analysis, artificial intelligence, public health.